Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review
A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.
FDA Clears Digital Therapeutic for the Treatment of Postpartum Depression
MamaLift Plus is a prescription-only digital therapeutic intervention for the treatment of mild to moderate postpartum depression using several different neurobehavioral interventions.
Sedating Antihistamines for Sleep: Safe for Breastfeeding Women and Their Babies?
Sleep disruption and insomnia are commonplace among postpartum women, and they often ask what medications are compatible with breastfeeding. What about sedating antihistamines?
Using AI and Natural Language Processing To Identify Postpartum Women with PTSD Related to Childbirth
Establishing noninvasive and low-cost data collection based on childbirth narratives for the identification of women with CB-PTSD could serve as an important first step to complement more extensive methods.
In Women with Bipolar Disorder, Loss of Sleep Related to Childbirth Increases Risk for Postpartum Psychosis
Loss of at least one night’s sleep at the time of labor and delivery is a potent risk factor for postpartum psychosis in women with bipolar disorder.
Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated
There is evidence that depression itself can increase risk for preeclampsia. In women with more severe depression, treatment with an SSRI antidepressant may decrease risk.
Maternal Depression Negatively Affects Fetal Growth During Critical Stage of Development
In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.
Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children
The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.
Essential Reads: The Use of Sedative-Hypnotic Drugs During Pregnancy
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
Which is Safer for the Treatment of Opioid Use Disorder During Pregnancy: Buprenorphine or Methadone?
In this large cohort study analyzing data from publicly insured Medicaid beneficiaries, the overall risk of malformations was lower with buprenorphine than with methadone.